Connection

ERXI WU to Drug Design

This is a "connection" page, showing publications ERXI WU has written about Drug Design.
Connection Strength

0.025
  1. Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-?B pathways with novel theanine derivatives. Oncotarget. 2014 Sep 30; 5(18):8528-43.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.